• Je něco špatně v tomto záznamu ?

The Abscopal Effect in the Era of Checkpoint Inhibitors

O. Kodet, K. Němejcova, K. Strnadová, A. Havlínová, P. Dundr, I. Krajsová, J. Štork, K. Smetana, L. Lacina

. 2021 ; 22 (13) : . [pub] 20210704

Jazyk angličtina Země Švýcarsko

Typ dokumentu kazuistiky, časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc21025401

Therapy targeting immune checkpoints represents an integral part of the treatment for patients suffering from advanced melanoma. However, the mechanisms of resistance are responsible for a lower therapeutic outcome than expected. Concerning melanoma, insufficient stimulation of the immune system by tumour neoantigens is a likely explanation. As shown previously, radiotherapy is a known option for increasing the production of tumour neoantigens and their release into the microenvironment. Consequently, neoantigens could be recognized by antigen presenting cells (APCs) and subjected to effector T lymphocytes. Enhancing the immune reaction can trigger the therapeutic response also at distant metastases, a phenomenon known as an abscopal effect (from "ab scopus", that is, away from the target). To illustrate this, we present the case of a 78-year old male treated by anti-CTLA-4/ipilimumab for metastatic melanoma. The patient received the standard four doses of ipilimumab administered every three weeks. However, the control CT scans detected disease progression in the form of axillary lymph nodes metastasis and liver metastasis two months after ipilimumab. At this stage, palliative cryotherapy of the skin metastases was initiated to alleviate the tumour burden. Surprisingly, the effect of cryotherapy was also observed in untreated metastases and deep subcutaneous metastases on the back. Moreover, we observed the disease remission of axillary lymph nodes and liver metastasis two months after the cryotherapy. The rarity of the abscopal effect suggests that even primed anti-tumour CD8+ T cells cannot overcome the tumour microenvironment's suppressive effect and execute immune clearance. However, the biological mechanism underlying this phenomenon is yet to be elucidated. The elicitation of a systemic response by cryotherapy with documented abscopal effect was rarely reported, although the immune response induction is presumably similar to a radiotherapy-induced one. The report is a combination case study and review of the abscopal effect in melanoma treated with checkpoint inhibitors.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21025401
003      
CZ-PrNML
005      
20211026133841.0
007      
ta
008      
211013s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ijms22137204 $2 doi
035    __
$a (PubMed)34281259
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Kodet, Ondřej $u Department of Dermatovenereology, First Faculty of Medicine and General University Hospital, Charles University, 128 00 Prague, Czech Republic $u Institute of Anatomy, First Faculty of Medicine, Charles University, 128 00 Prague, Czech Republic $u Biotechnology and Biomedicine Center, Academy of Science and Charles University, 252 50 Vestec, Czech Republic
245    14
$a The Abscopal Effect in the Era of Checkpoint Inhibitors / $c O. Kodet, K. Němejcova, K. Strnadová, A. Havlínová, P. Dundr, I. Krajsová, J. Štork, K. Smetana, L. Lacina
520    9_
$a Therapy targeting immune checkpoints represents an integral part of the treatment for patients suffering from advanced melanoma. However, the mechanisms of resistance are responsible for a lower therapeutic outcome than expected. Concerning melanoma, insufficient stimulation of the immune system by tumour neoantigens is a likely explanation. As shown previously, radiotherapy is a known option for increasing the production of tumour neoantigens and their release into the microenvironment. Consequently, neoantigens could be recognized by antigen presenting cells (APCs) and subjected to effector T lymphocytes. Enhancing the immune reaction can trigger the therapeutic response also at distant metastases, a phenomenon known as an abscopal effect (from "ab scopus", that is, away from the target). To illustrate this, we present the case of a 78-year old male treated by anti-CTLA-4/ipilimumab for metastatic melanoma. The patient received the standard four doses of ipilimumab administered every three weeks. However, the control CT scans detected disease progression in the form of axillary lymph nodes metastasis and liver metastasis two months after ipilimumab. At this stage, palliative cryotherapy of the skin metastases was initiated to alleviate the tumour burden. Surprisingly, the effect of cryotherapy was also observed in untreated metastases and deep subcutaneous metastases on the back. Moreover, we observed the disease remission of axillary lymph nodes and liver metastasis two months after the cryotherapy. The rarity of the abscopal effect suggests that even primed anti-tumour CD8+ T cells cannot overcome the tumour microenvironment's suppressive effect and execute immune clearance. However, the biological mechanism underlying this phenomenon is yet to be elucidated. The elicitation of a systemic response by cryotherapy with documented abscopal effect was rarely reported, although the immune response induction is presumably similar to a radiotherapy-induced one. The report is a combination case study and review of the abscopal effect in melanoma treated with checkpoint inhibitors.
650    _2
$a senioři $7 D000368
650    _2
$a antigen prezentující buňky $x imunologie $7 D000938
650    _2
$a antigeny nádorové $x metabolismus $7 D000951
650    _2
$a kryoterapie $7 D017679
650    _2
$a lidé $7 D006801
650    _2
$a inhibitory kontrolních bodů $x terapeutické užití $7 D000082082
650    _2
$a ipilimumab $x terapeutické užití $7 D000074324
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a melanom $x imunologie $x sekundární $x terapie $7 D008545
650    _2
$a modely imunologické $7 D018448
650    _2
$a paliativní péče $7 D010166
650    _2
$a nádory kůže $x imunologie $x patologie $x terapie $7 D012878
650    _2
$a výsledek terapie $7 D016896
650    _2
$a nádorové mikroprostředí $x imunologie $7 D059016
655    _2
$a kazuistiky $7 D002363
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Němejcova, Kristýna $u Institute of Pathology, First Faculty of Medicine and General University Hospital, Charles University, 128 00 Prague, Czech Republic
700    1_
$a Strnadová, Karolína $u Institute of Anatomy, First Faculty of Medicine, Charles University, 128 00 Prague, Czech Republic
700    1_
$a Havlínová, Andrea $u Department of Dermatovenereology, First Faculty of Medicine and General University Hospital, Charles University, 128 00 Prague, Czech Republic
700    1_
$a Dundr, Pavel $u Institute of Pathology, First Faculty of Medicine and General University Hospital, Charles University, 128 00 Prague, Czech Republic
700    1_
$a Krajsová, Ivana $u Department of Dermatovenereology, First Faculty of Medicine and General University Hospital, Charles University, 128 00 Prague, Czech Republic
700    1_
$a Štork, Jiří $u Department of Dermatovenereology, First Faculty of Medicine and General University Hospital, Charles University, 128 00 Prague, Czech Republic
700    1_
$a Smetana, Karel $u Institute of Anatomy, First Faculty of Medicine, Charles University, 128 00 Prague, Czech Republic $u Biotechnology and Biomedicine Center, Academy of Science and Charles University, 252 50 Vestec, Czech Republic
700    1_
$a Lacina, Lukáš $u Department of Dermatovenereology, First Faculty of Medicine and General University Hospital, Charles University, 128 00 Prague, Czech Republic $u Institute of Anatomy, First Faculty of Medicine, Charles University, 128 00 Prague, Czech Republic $u Biotechnology and Biomedicine Center, Academy of Science and Charles University, 252 50 Vestec, Czech Republic
773    0_
$w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 22, č. 13 (2021)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34281259 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20211026133847 $b ABA008
999    __
$a ok $b bmc $g 1714442 $s 1145908
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 22 $c 13 $e 20210704 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
LZP    __
$a Pubmed-20211013

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...